Clinical Trials on Allergy to Grass Pollen in Belgium

Total 6 results

Biomay AG

Completed

Phase II Study of Grass Pollen Allergy Vaccine BM32

Grass Pollen Allergy

Austria, Belgium, Denmark, Germany, Netherlands, Slovenia
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

Hay Fever | Grass Pollen Allergy

Belgium, France, Luxembourg
Hippocreates

Completed

Validation and Reproducibility of S.P.A.T. With Allergens

Allergy Pollen | Allergy to House Dust

Belgium
Regeneron Pharmaceuticals

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of a Single Dose of REGN5713-5714-5715 in Healthy Adult Participants

Healthy Volunteers | Birch Pollen Allergy

Belgium
Regeneron Pharmaceuticals

Terminated

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

Allergic Rhinitis Due to Cat Allergy

United States, Belgium, Germany, Poland, Canada, France
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis

Chronic Rhinosinusitis With Nasal Polyps | Hyperactivity | Allergic Rhinitis Due to House Dust Mite

Belgium

3

Subscribe